| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.44 | 0.003 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |